1-2 of 2
Kyeoung-Soo Park
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interluekin-10 (IL-10) Promoter Gene Polymorphism (−819*C) Associated with Poor Clinical Outcome in DLBCL Patients Treated with R (Rituximab)-CHOP Regimen as a First Line.

Yeo-Kyeoung Kim, Hee-Nam Kim, Je-Jung Lee, Deok-Hwan Yang, Il-Kwon Lee, Kyeoung-Soo Park, Hyeoung-Joon Kim
Journal: Blood
Blood (2005) 106 (11): 1923.
https://doi.org/10.1182/blood.V106.11.1923.1923
Published: 2005
Journal Articles

The Feasibility Study for Using FLT3/ITD as a Marker of the Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML) by Serial Analysis in Diagnosis, Remission and Relapse.

Yeo-Kyeoung Kim, Hee-Nam Kim, Il-Kwon Lee, Su-Mi Lee, Hyeok Shim, Moo-Rim Park, Kyeoung-Soo Park, Deok-Hwan Yang, Je-Jung Lee, Hyeoung-Joon Kim
Journal: Blood
Blood (2005) 106 (11): 4515.
https://doi.org/10.1182/blood.V106.11.4515.4515
Published: 2005